APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Gastro Esophageal Reflux Disease (GERD) Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Gastro Esophageal Reflux Disease (GERD) Drug Market Analysis and Forecast 2026-2032

Report ID 173994180226 December 2025194 pages

Choose your research edition.

Industry ResearchGastro Esophageal Reflux Disease (GERD) Drug Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Gastro Esophageal Reflux Disease (GERD) Drug Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Gastro Esophageal Reflux Disease (GERD) Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gastro Esophageal Reflux Disease (GERD) Drug Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Gastro Esophageal Reflux Disease (GERD) Drug Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Gastro Esophageal Reflux Disease (GERD) Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Gastro Esophageal Reflux Disease (GERD) Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Gastro Esophageal Reflux Disease (GERD) Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Gastro Esophageal Reflux Disease (GERD) Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Gastro Esophageal Reflux Disease (GERD) Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Gastro Esophageal Reflux Disease (GERD) Drug include Addex Therapeutics, Aros Pharma, AstraZeneca, Plc., Medtronic, Takeda Pharmaceutical Company Limited, The Kroger Co., GlaxoSmithKline, Pfizer and Merck, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Gastro Esophageal Reflux Disease (GERD) Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Gastro Esophageal Reflux Disease (GERD) Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Gastro Esophageal Reflux Disease (GERD) Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gastro Esophageal Reflux Disease (GERD) Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Gastro Esophageal Reflux Disease (GERD) Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Gastro Esophageal Reflux Disease (GERD) Drug sales, projected growth trends, production technology, application and end-user industry.

Gastro Esophageal Reflux Disease (GERD) Drug Segment by Company

Addex Therapeutics

Aros Pharma

AstraZeneca, Plc.

Medtronic

Takeda Pharmaceutical Company Limited

The Kroger Co.

GlaxoSmithKline

Pfizer

Merck

Novartis AG

Gastro Esophageal Reflux Disease (GERD) Drug Segment by Type

H2 Receptor Antagonist

Proton Pump Inhibitor (PPi)

Antacids

Gastro Esophageal Reflux Disease (GERD) Drug Segment by Application

Clinic

Hospital

Medical Center

Others

Gastro Esophageal Reflux Disease (GERD) Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gastro Esophageal Reflux Disease (GERD) Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gastro Esophageal Reflux Disease (GERD) Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gastro Esophageal Reflux Disease (GERD) Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Gastro Esophageal Reflux Disease (GERD) Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Gastro Esophageal Reflux Disease (GERD) Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gastro Esophageal Reflux Disease (GERD) Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. H2 Receptor Antagonist Major Manufacturers Table 3. Proton Pump Inhibitor (PPi) Major Manufacturers Table 4. Antacids Major Manufacturers Table 5. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Clinic Major Manufacturers Table 7. Hospital Major Manufacturers Table 8. Medical Center Major Manufacturers Table 9. Others Major Manufacturers Table 10. Gastro Esophageal Reflux Disease (GERD) Drug Industry Trends Table 11. Gastro Esophageal Reflux Disease (GERD) Drug Industry Drivers Table 12. Gastro Esophageal Reflux Disease (GERD) Drug Industry Opportunities and Challenges Table 13. Gastro Esophageal Reflux Disease (GERD) Drug Industry Restraints Table 14. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Region (2021-2026) Table 18. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Region (2027-2032) Table 19. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region (2021-2026) & (K Units) Table 21. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region (2027-2032) & (K Units) Table 22. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Region (2021-2026) Table 23. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Region (2027-2032) Table 24. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Manufacturers (2021-2026) Table 28. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Gastro Esophageal Reflux Disease (GERD) Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Gastro Esophageal Reflux Disease (GERD) Drug Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Gastro Esophageal Reflux Disease (GERD) Drug Manufacturers, Product Type & Application Table 32. Global Gastro Esophageal Reflux Disease (GERD) Drug Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Gastro Esophageal Reflux Disease (GERD) Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Type (2021-2026) Table 39. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Type (2027-2032) Table 40. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2021-2026) & (K Units) Table 42. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2027-2032) & (K Units) Table 43. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2021-2026) Table 44. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2027-2032) Table 45. Global Gastro Esophageal Reflux Disease (GERD) Drug Price by Type (2021-2026) & (US$/Unit) Table 46. Global Gastro Esophageal Reflux Disease (GERD) Drug Price by Type (2027-2032) & (US$/Unit) Table 47. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Application (2021-2026) Table 51. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Application (2027-2032) Table 52. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2021-2026) & (K Units) Table 54. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2027-2032) & (K Units) Table 55. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2021-2026) Table 56. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2027-2032) Table 57. Global Gastro Esophageal Reflux Disease (GERD) Drug Price by Application (2021-2026) & (US$/Unit) Table 58. Global Gastro Esophageal Reflux Disease (GERD) Drug Price by Application (2027-2032) & (US$/Unit) Table 59. Addex Therapeutics Company Information Table 60. Addex Therapeutics Business Overview Table 61. Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio Table 63. Addex Therapeutics Recent Development Table 64. Aros Pharma Company Information Table 65. Aros Pharma Business Overview Table 66. Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio Table 68. Aros Pharma Recent Development Table 69. AstraZeneca, Plc. Company Information Table 70. AstraZeneca, Plc. Business Overview Table 71. AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio Table 73. AstraZeneca, Plc. Recent Development Table 74. Medtronic Company Information Table 75. Medtronic Business Overview Table 76. Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio Table 78. Medtronic Recent Development Table 79. Takeda Pharmaceutical Company Limited Company Information Table 80. Takeda Pharmaceutical Company Limited Business Overview Table 81. Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio Table 83. Takeda Pharmaceutical Company Limited Recent Development Table 84. The Kroger Co. Company Information Table 85. The Kroger Co. Business Overview Table 86. The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio Table 88. The Kroger Co. Recent Development Table 89. GlaxoSmithKline Company Information Table 90. GlaxoSmithKline Business Overview Table 91. GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio Table 93. GlaxoSmithKline Recent Development Table 94. Pfizer Company Information Table 95. Pfizer Business Overview Table 96. Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio Table 98. Pfizer Recent Development Table 99. Merck Company Information Table 100. Merck Business Overview Table 101. Merck Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Merck Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio Table 103. Merck Recent Development Table 104. Novartis AG Company Information Table 105. Novartis AG Business Overview Table 106. Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio Table 108. Novartis AG Recent Development Table 109. North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2021-2026) & (US$ Million) Table 110. North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2027-2032) & (US$ Million) Table 111. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2021-2026) & (K Units) Table 112. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2027-2032) & (K Units) Table 113. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 114. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 115. North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2021-2026) & (US$ Million) Table 116. North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2027-2032) & (US$ Million) Table 117. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2021-2026) & (K Units) Table 118. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2027-2032) & (K Units) Table 119. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 120. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 121. North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 123. North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 124. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 125. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2021-2026) & (K Units) Table 126. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2027-2032) & (K Units) Table 127. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 128. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 129. United States Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2021-2032) & (US$ Million) Table 130. Canada Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2021-2032) & (US$ Million) Table 131. Mexico Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2021-2032) & (US$ Million) Table 132. Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2021-2026) & (US$ Million) Table 133. Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2027-2032) & (US$ Million) Table 134. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2021-2026) & (K Units) Table 135. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2027-2032) & (K Units) Table 136. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 137. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 138. Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2021-2026) & (US$ Million) Table 139. Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2027-2032) & (US$ Million) Table 140. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2021-2026) & (K Units) Table 141. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2027-2032) & (K Units) Table 142. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 143. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 144. Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 146. Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 147. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 148. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2021-2026) & (K Units) Table 149. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2027-2032) & (K Units) Table 150. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 151. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 152. Germany Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2021-2032) & (US$ Million) Table 153. France Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2021-2032) & (US$ Million) Table 154. U.K. Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2021-2032) & (US$ Million) Table 155. Italy Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2021-2032) & (US$ Million) Table 156. Russia Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2021-2032) & (US$ Million) Table 157. Spain Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2021-2032) & (US$ Million) Table 158. Netherlands Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2021-2032) & (US$ Million) Table 159. Switzerland Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2021-2032) & (US$ Million) Table 160. Sweden Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2021-2032) & (US$ Million) Table 161. Poland Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2021-2032) & (US$ Million) Table 162. China Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2021-2026) & (US$ Million) Table 163. China Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2027-2032) & (US$ Million) Table 164. China Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2021-2026) & (K Units) Table 165. China Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2027-2032) & (K Units) Table 166. China Gastro Esophageal Reflux Disease (GERD) Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 167. China Gastro Esophageal Reflux Disease (GERD) Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 168. China Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2021-2026) & (US$ Million) Table 169. China Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2027-2032) & (US$ Million) Table 170. China Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2021-2026) & (K Units) Table 171. China Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2027-2032) & (K Units) Table 172. China Gastro Esophageal Reflux Disease (GERD) Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 173. China Gastro Esophageal Reflux Disease (GERD) Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 174. Asia Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2021-2026) & (US$ Million) Table 175. Asia Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2027-2032) & (US$ Million) Table 176. Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2021-2026) & (K Units) Table 177. Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2027-2032) & (K Units) Table 178. Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 179. Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 180. Asia Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2021-2026) & (US$ Million) Table 181. Asia Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2027-2032) & (US$ Million) Table 182. Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2021-2026) & (K Units) Table 183. Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2027-2032) & (K Units) Table 184. Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 185. Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 186. Asia Gastro Esophageal Reflux Disease (GERD) Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 187. Asia Gastro Esophageal Reflux Disease (GERD) Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 188. Asia Gastro Esophageal Reflux Disease (GERD) Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 189. Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 190. Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2021-2026) & (K Units) Table 191. Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2027-2032) & (K Units) Table 192. Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 193. Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 194. Japan Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2021-2032) & (US$ Million) Table 195. South Korea Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2021-2032) & (US$ Million) Table 196. India Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2021-2032) & (US$ Million) Table 197. Australia Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2021-2032) & (US$ Million) Table 198. Taiwan Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2021-2032) & (US$ Million) Table 199. Southeast Asia Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2021-2032) & (US$ Million) Table 200. SAMEA Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2021-2026) & (US$ Million) Table 201. SAMEA Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2027-2032) & (US$ Million) Table 202. SAMEA Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2021-2026) & (K Units) Table 203. SAMEA Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2027-2032) & (K Units) Table 204. SAMEA Gastro Esophageal Reflux Disease (GERD) Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 205. SAMEA Gastro Esophageal Reflux Disease (GERD) Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 206. SAMEA Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2021-2026) & (US$ Million) Table 207. SAMEA Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2027-2032) & (US$ Million) Table 208. SAMEA Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2021-2026) & (K Units) Table 209. SAMEA Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2027-2032) & (K Units) Table 210. SAMEA Gastro Esophageal Reflux Disease (GERD) Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 211. SAMEA Gastro Esophageal Reflux Disease (GERD) Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 212. SAMEA Gastro Esophageal Reflux Disease (GERD) Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 213. SAMEA Gastro Esophageal Reflux Disease (GERD) Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 214. SAMEA Gastro Esophageal Reflux Disease (GERD) Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 215. SAMEA Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 216. SAMEA Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2021-2026) & (K Units) Table 217. SAMEA Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2027-2032) & (K Units) Table 218. SAMEA Gastro Esophageal Reflux Disease (GERD) Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 219. SAMEA Gastro Esophageal Reflux Disease (GERD) Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 220. Brazil Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2021-2032) & (US$ Million) Table 221. Argentina Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2021-2032) & (US$ Million) Table 222. Chile Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2021-2032) & (US$ Million) Table 223. Colombia Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2021-2032) & (US$ Million) Table 224. Peru Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2021-2032) & (US$ Million) Table 225. Saudi Arabia Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2021-2032) & (US$ Million) Table 226. Israel Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2021-2032) & (US$ Million) Table 227. UAE Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2021-2032) & (US$ Million) Table 228. Turkey Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2021-2032) & (US$ Million) Table 229. Iran Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2021-2032) & (US$ Million) Table 230. Egypt Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2021-2032) & (US$ Million) Table 231. Key Raw Materials Table 232. Raw Materials Key Suppliers Table 233. Gastro Esophageal Reflux Disease (GERD) Drug Distributors List Table 234. Gastro Esophageal Reflux Disease (GERD) Drug Customers List Table 235. Research Programs/Design for This Report Table 236. Authors List of This Report Table 237. Secondary Sources Table 238. Primary Sources List of Figures Figure 1. Gastro Esophageal Reflux Disease (GERD) Drug Image Figure 2. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. H2 Receptor Antagonist Image Figure 5. Proton Pump Inhibitor (PPi) Image Figure 6. Antacids Image Figure 7. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size Share 2021 VS 2025 VS 2032 Figure 9. Clinic Image Figure 10. Hospital Image Figure 11. Medical Center Image Figure 12. Others Image Figure 13. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue (2021-2032) & (US$ Million) Figure 15. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Region (2021-2032) Figure 18. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (2021-2032) & (K Units) Figure 19. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Gastro Esophageal Reflux Disease (GERD) Drug Sales YoY (2021-2032) & (K Units) Figure 22. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales YoY (2021-2032) & (K Units) Figure 23. China Gastro Esophageal Reflux Disease (GERD) Drug Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) Gastro Esophageal Reflux Disease (GERD) Drug Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales YoY (2021-2032) & (K Units) Figure 26. Global Gastro Esophageal Reflux Disease (GERD) Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Gastro Esophageal Reflux Disease (GERD) Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Type (2021-2032) Figure 32. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2021-2032) Figure 35. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Application (2021-2032) Figure 38. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2021-2032) Figure 41. North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Type (2021-2032) Figure 42. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Type (2021-2032) Figure 43. North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Application (2021-2032) Figure 44. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Application (2021-2032) Figure 45. North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Country (2021-2032) Figure 46. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Country (2021-2032) Figure 47. Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Type (2021-2032) Figure 48. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Type (2021-2032) Figure 49. Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Application (2021-2032) Figure 50. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Application (2021-2032) Figure 51. Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Country (2021-2032) Figure 52. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Country (2021-2032) Figure 53. China Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Type (2021-2032) Figure 54. China Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Type (2021-2032) Figure 55. China Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Application (2021-2032) Figure 56. China Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Application (2021-2032) Figure 57. Asia Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Type (2021-2032) Figure 58. Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Type (2021-2032) Figure 59. Asia Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Application (2021-2032) Figure 60. Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Application (2021-2032) Figure 61. Asia Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Country (2021-2032) Figure 62. Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Country (2021-2032) Figure 63. SAMEA Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Type (2021-2032) Figure 64. SAMEA Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Type (2021-2032) Figure 65. SAMEA Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Application (2021-2032) Figure 66. SAMEA Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Application (2021-2032) Figure 67. SAMEA Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Country (2021-2032) Figure 68. SAMEA Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Country (2021-2032) Figure 69. Gastro Esophageal Reflux Disease (GERD) Drug Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Gastro Esophageal Reflux Disease (GERD) Drug Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • H2 Receptor Antagonist
  • Proton Pump Inhibitor (PPi)
  • Antacids
Applications
  • Clinic
  • Hospital
  • Medical Center
  • Others
Companies covered
  • Addex Therapeutics
  • Aros Pharma
  • AstraZeneca, Plc.
  • Medtronic
  • Takeda Pharmaceutical Company Limited
  • The Kroger Co.
  • GlaxoSmithKline
  • Pfizer
  • Merck
  • Novartis AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Gastro Esophageal Reflux Disease (GERD) Drug Market by Type
  3. 1.2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 H2 Receptor Antagonist
  5. 1.2.3 Proton Pump Inhibitor (PPi)
  6. 1.2.4 Antacids
  7. 1.3 Gastro Esophageal Reflux Disease (GERD) Drug Market by Application
  8. 1.3.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Clinic
  10. 1.3.3 Hospital
  11. 1.3.4 Medical Center
  12. 1.3.5 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Gastro Esophageal Reflux Disease (GERD) Drug Market Dynamics
  1. 2.1 Gastro Esophageal Reflux Disease (GERD) Drug Industry Trends
  2. 2.2 Gastro Esophageal Reflux Disease (GERD) Drug Industry Drivers
  3. 2.3 Gastro Esophageal Reflux Disease (GERD) Drug Industry Opportunities and Challenges
  4. 2.4 Gastro Esophageal Reflux Disease (GERD) Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region
  3. 3.2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region
  9. 3.4.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Manufacturers
  2. 4.1.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Manufacturers
  6. 4.2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Gastro Esophageal Reflux Disease (GERD) Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Gastro Esophageal Reflux Disease (GERD) Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Gastro Esophageal Reflux Disease (GERD) Drug Manufacturers, Product Type & Application
  13. 4.7 Global Gastro Esophageal Reflux Disease (GERD) Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Market CR5 and HHI
  16. 4.8.2 2025 Gastro Esophageal Reflux Disease (GERD) Drug Tier 1, Tier 2, and Tier 3
5 Gastro Esophageal Reflux Disease (GERD) Drug Market by Type
  1. 5.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type
  2. 5.1.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type
  6. 5.2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Price by Type
6 Gastro Esophageal Reflux Disease (GERD) Drug Market by Application
  1. 6.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application
  2. 6.1.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application
  6. 6.2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Price by Application
7 Company Profiles
  1. 7.1 Addex Therapeutics
  2. 7.1.1 Addex Therapeutics Company Information
  3. 7.1.2 Addex Therapeutics Business Overview
  4. 7.1.3 Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
  6. 7.1.5 Addex Therapeutics Recent Developments
  7. 7.2 Aros Pharma
  8. 7.2.1 Aros Pharma Company Information
  9. 7.2.2 Aros Pharma Business Overview
  10. 7.2.3 Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
  12. 7.2.5 Aros Pharma Recent Developments
  13. 7.3 AstraZeneca, Plc.
  14. 7.3.1 AstraZeneca, Plc. Company Information
  15. 7.3.2 AstraZeneca, Plc. Business Overview
  16. 7.3.3 AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
  18. 7.3.5 AstraZeneca, Plc. Recent Developments
  19. 7.4 Medtronic
  20. 7.4.1 Medtronic Company Information
  21. 7.4.2 Medtronic Business Overview
  22. 7.4.3 Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
  24. 7.4.5 Medtronic Recent Developments
  25. 7.5 Takeda Pharmaceutical Company Limited
  26. 7.5.1 Takeda Pharmaceutical Company Limited Company Information
  27. 7.5.2 Takeda Pharmaceutical Company Limited Business Overview
  28. 7.5.3 Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
  30. 7.5.5 Takeda Pharmaceutical Company Limited Recent Developments
  31. 7.6 The Kroger Co.
  32. 7.6.1 The Kroger Co. Company Information
  33. 7.6.2 The Kroger Co. Business Overview
  34. 7.6.3 The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
  36. 7.6.5 The Kroger Co. Recent Developments
  37. 7.7 GlaxoSmithKline
  38. 7.7.1 GlaxoSmithKline Company Information
  39. 7.7.2 GlaxoSmithKline Business Overview
  40. 7.7.3 GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
  42. 7.7.5 GlaxoSmithKline Recent Developments
  43. 7.8 Pfizer
  44. 7.8.1 Pfizer Company Information
  45. 7.8.2 Pfizer Business Overview
  46. 7.8.3 Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
  48. 7.8.5 Pfizer Recent Developments
  49. 7.9 Merck
  50. 7.9.1 Merck Company Information
  51. 7.9.2 Merck Business Overview
  52. 7.9.3 Merck Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Merck Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
  54. 7.9.5 Merck Recent Developments
  55. 7.10 Novartis AG
  56. 7.10.1 Novartis AG Company Information
  57. 7.10.2 Novartis AG Business Overview
  58. 7.10.3 Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
  60. 7.10.5 Novartis AG Recent Developments
8 North America
  1. 8.1 North America Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Type
  2. 8.1.1 North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Gastro Esophageal Reflux Disease (GERD) Drug Price by Type (2021-2032)
  5. 8.2 North America Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Application
  6. 8.2.1 North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Gastro Esophageal Reflux Disease (GERD) Drug Price by Application (2021-2032)
  9. 8.3 North America Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Country
  10. 8.3.1 North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Gastro Esophageal Reflux Disease (GERD) Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Type
  2. 9.1.1 Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Gastro Esophageal Reflux Disease (GERD) Drug Price by Type (2021-2032)
  5. 9.2 Europe Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Application
  6. 9.2.1 Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Gastro Esophageal Reflux Disease (GERD) Drug Price by Application (2021-2032)
  9. 9.3 Europe Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Country
  10. 9.3.1 Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Gastro Esophageal Reflux Disease (GERD) Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Type
  2. 10.1.1 China Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2021-2032)
  4. 10.1.3 China Gastro Esophageal Reflux Disease (GERD) Drug Price by Type (2021-2032)
  5. 10.2 China Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Application
  6. 10.2.1 China Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2021-2032)
  8. 10.2.3 China Gastro Esophageal Reflux Disease (GERD) Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Type
  2. 11.1.1 Asia Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Gastro Esophageal Reflux Disease (GERD) Drug Price by Type (2021-2032)
  5. 11.2 Asia Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Application
  6. 11.2.1 Asia Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Gastro Esophageal Reflux Disease (GERD) Drug Price by Application (2021-2032)
  9. 11.3 Asia Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Country
  10. 11.3.1 Asia Gastro Esophageal Reflux Disease (GERD) Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Gastro Esophageal Reflux Disease (GERD) Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Type
  2. 12.1.1 SAMEA Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Gastro Esophageal Reflux Disease (GERD) Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Application
  6. 12.2.1 SAMEA Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Gastro Esophageal Reflux Disease (GERD) Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Country
  10. 12.3.1 SAMEA Gastro Esophageal Reflux Disease (GERD) Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Gastro Esophageal Reflux Disease (GERD) Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Gastro Esophageal Reflux Disease (GERD) Drug Value Chain Analysis
  2. 13.1.1 Gastro Esophageal Reflux Disease (GERD) Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Gastro Esophageal Reflux Disease (GERD) Drug Production Mode & Process
  6. 13.2 Gastro Esophageal Reflux Disease (GERD) Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Gastro Esophageal Reflux Disease (GERD) Drug Distributors
  9. 13.2.3 Gastro Esophageal Reflux Disease (GERD) Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst